ICI-Treated Synchronous mRCC Is Associated With Negative Sur

Patients with synchronous metastatic renal cell carcinoma who received first-line immunotherapy had worse survival outcomes compared with those with metachronous metastatic renal cell carcinoma.

Related Keywords

Utah , United States , Boston , Massachusetts , Georges Gebrael , End Results Program , International Metastatic , International Metastatic Renal Cell Carcinoma Database , Division Of Medical Oncology , Department Of Internal Medicine , National Cancer Institute Surveillance , Database Consortium , Kidney Cancer Research Summit , Cancer Research , Medical Oncology , Internal Medicine , Utah Huntsman Cancer Institute , Salt Lake City , End Results , Cancer Research Summit , Cancer Institute Surveillance , Accessed July , News , Genitourinary Cancers , Immunotherapy In Gu Cancers , Immuno Oncology , Renal Cell Carcinoma ,